Treatment-associated liver-toxicity in patients with advanced metastatic renal cell carcinoma (mRCC) treated with Pazopanib

被引：0
|
作者：
Rickmann, M. [1 ]
Seidel, C. [2 ]
Reuter, C. [1 ]
Trummer, A. [1 ]
Ganser, A. [1 ]
Gruenwald, V [1 ]
机构：
[1] Hannover Med Sch, D-30623 Hannover, Germany
[2] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany
来源：
ONKOLOGIE | 2013年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [1] Liver toxicity in patients with metastatic renal cell carcinoma treated with pazopanib therapy
    Lim, L.
    Mathias, J.
    Lampron, M.
    Fehr, M.
    Gruenwald, V.
    Khan, M.
    Crabb, S.
    Choueiri, T.
    Powles, T.
    Rini, B.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S660 - S660
  • [2] LIVER TOXICITY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH PAZOPANIB THERAPY
    Lim, F. L.
    Shamash, J.
    Wilson, P.
    Powles, T.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 290 - 290
  • [3] Real-word evidence in patients treated with pazopanib for advanced/metastatic renal cell carcinoma (mRCC): The APOLON study.
    Thiery-Vuillemin, Antoine
    Barthelemy, Philippe
    Lebret, Thierry
    Bigot, Pierre
    Stein, Ulrich
    Dourthe, Louis Marie
    Longo, Raffaele
    De La Cruz, Jeannine
    Sevaux, Sandra
    Tindel, Malka
    Albiges, Laurence
    Escudier, Bernard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [4] Pazopanib for the Treatment of Patients with Advanced Renal Cell Carcinoma
    Lang, Joshua M.
    Harrison, Michael R.
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2010, 4 : 95 - 105
  • [5] A phase II study of patients with advanced or metastatic renal cell carcinoma (mRCC) receiving pazopanib after previous checkpoint inhibitor treatment
    Powles, T. B.
    Oudard, S.
    Grunwald, V.
    Calvo, E.
    Michaelson, M. D.
    Burotto, M.
    Melichar, B.
    Tyagi, R.
    Hilmi, F.
    Gaur, A.
    Hirschberg, Y.
    Heng, D.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S564 - S564
  • [6] Pazopanib for the Treatment of Metastatic Renal Cell Carcinoma
    Pick, Amy M.
    Nystrom, Kelly K.
    [J]. CLINICAL THERAPEUTICS, 2012, 34 (03) : 511 - 520
  • [7] Pazopanib in the treatment of advanced renal cell carcinoma
    Cella, David
    Beaumont, Jennifer L.
    [J]. THERAPEUTIC ADVANCES IN UROLOGY, 2016, 8 (01) : 61 - 69
  • [8] Australian Treatment Practices for Patients with Metastatic Renal Cell Carcinoma (MRCC)
    Liow, Elizabeth
    Baenziger, Olivia
    Corrente, Claudia
    Law, Nicholas
    Azad, Arun
    Shapiro, Julia
    Shapiro, Jeremy
    Weickhardt, Andrew
    Schmidt, Andrew
    Parnis, Francis
    Wong, Shirley
    Parente, Phillip
    Anton, Angelyn
    Pezaro, Carmel
    Tran, Ben
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 55 - 55
  • [9] CARDIOTOXICITY IN METASTATIC RENAL CELL CARCINOMA (mRCC) PATIENTS TREATED WITH SUNITINIB (SU)
    Ballatore, Valentina
    Prati, Veronica
    Ruatta, Fiorella
    Galizia, Danilo
    Grignani, Giovanni
    Aglietta, Massimo
    Ortega, Cinzia
    [J]. ANTICANCER RESEARCH, 2012, 32 (05) : 1876 - 1877
  • [10] Treatment-Associated Adverse Event Management in the Advanced Renal Cell Carcinoma Patient Treated with Targeted Therapies
    Ravaud, Alain
    [J]. ONCOLOGIST, 2011, 16 : 32 - 44
12345